Filter posts

The Challenges and Risks of Adopting Foreign Price Controls

The Trump Administration is moving forward with a plan to import foreign price controls into …

ICYMI: Biopharmaceutical Companies Aren’t Free-Riding on Government Research

Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm …

Discrimination Against Vulnerable Patients Is Nothing New

Transformative therapies are advancing like never before, and a new class of medicines are changing …

National Immunization Awareness Month Is a Reminder About the Value of Vaccines

Writing for Morning Consult, Dr. Judy Monroe, president and CEO of the CDC Foundation, highlights …

New Coalition to Raise Awareness of Antimicrobial Resistance Threat, Call for Urgent Solutions

The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced …

BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN

BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest …

Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs

Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of …

Why Are Patients Facing Higher Costs When They Go to the Pharmacy?

BIO is out with a new whiteboard video that explores why more and more patients …

Experts Weigh In on the Dangers of Importing Foreign Price Controls

Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead …

Rare Disease Drug Development Increases but Challenges Remain

In a recent study published by Tufts University, researchers found that rare disease drug development …